WASHINGTON — Pharmacy benefit managers are a key focus of debate about elevated drug pricing that has come before a U.S. Senate committee. The National Community Pharmacists Association (NCPA) and the Senior Care Pharmacy Coalition (SCPC) called for PBM reform in written testimony submitted to a Senate Health, Education, Labor and Pensions (HELP) Committee hearing
Direct and indirect remuneration (DIR) is one component of the complex Medicare Part D payment system. In the past several months, the issue of DIR increasingly has become a source of contention between various players in the Part D program. Pharmacies, the Centers for Medicare and Medicaid Services (CMS), and members of Congress have expressed
ALEXANDRIA, Va. — A group 118 health care stakeholders, including chain drug retailers, have called on Congress to crack down on direct and indirect remuneration (DIR) fees in Medicare Part D. Mobilized by the National Community Pharmacists Association (NCPA), the broad coalition sent letters to the Senate and House of Representatives to voice their support
ALEXANDRIA, Va. — Chain drug retailers were among 118 health care stakeholders calling on Congress this week to crack down on direct and indirect remuneration fees in Medicare Part D. Marshaled by the National Community Pharmacists Association, the broad coalition — also including independent pharmacies, pharmacy trade groups, drug distributors, pharmacy buying groups, supermarket retailers,
ALEXANDRIA, Va. — The National Community Pharmacists Association has called on Congress to hold hearings on legislation that would crack down on direct and indirect remuneration (DIR) fees. NCPA said it has sent letters to the chair and ranking member of the Senate Finance Committee and to the chair and ranking members of the House
